We're proud of our history as an innovative, mission-driven organization. FactSet (a) does not make any express or implied warranties of any kind regarding the data, including, without limitation, any warranty of merchantability or fitness for a particular purpose or use; and (b) shall not be liable for any errors, incompleteness, interruption or delay, action taken in reliance on any data, or for any damages resulting therefrom. The median estimated compensation for executives at Centene Corporation including base salary and bonus is $235,905, or $113 per hour. All forward-looking statements included in this press release are based on information available to us on the date hereof. He served as Senior Vice President of Centene Corp. from November 2006 to November 26, 2012. (1) Medicare includes Medicare Advantage, Medicare Supplement, D-SNPs, and Medicare PDP. GovCon Wire provides you with Daily Updates and News Briefings about Articles. Centene now offers a wide range of medical services to government-run healthcare services and programs catering to over 26+ million managed care members in all 50 states and three international markets. Sarah M. London Chief Executive Officer, Director Drew Asher Chief Financial Officer Jim Murray Chief Operating Officer Alice H. Chen Chief Health Officer Brian LeClaire Chief Information Officer Jessica L. Blume Director H. James Dallas Chairman of the Centene Board of Director Here is the list of the latest directors and independent directors of the company. Leverage your professional network, and get hired. Previously, he held senior finance positions at Aetna as well . Elizabeth Brinn is the founder of Centene Corporation. Vice President Talent Acquisition at Centene Corporation - Comparably Sources: CoinDesk (Bitcoin), Kraken (all other cryptocurrencies), Calendars and Economy: 'Actual' numbers are added to the table after economic reports are released. Effective March 1, 2021, the following appointments have been made: Mr. Layton, Ms. London, and Ms. Bagley will continue to report toMichael Neidorff, Chairman, President and Chief Executive Officer ofCentene. This list of important factors is not intended to be exhaustive. Steady, organic growth and a series of strategic acquisitions have transformed us from a regional player to a national powerhouse. Centene aims to extend its global presence in Europe by partnering with Ribera Salud to provide high-quality and efficient health care to professionals, citizens, and institutions. Centene Corporation Reports First Quarter 2023 Results The Company takes a local approach - with local brands and local teams - to provide fully integrated, high-quality, and cost-effective services to government-sponsored and commercial healthcare programs, focusing on under-insured and uninsured individuals. Kenneth Burdick is a retired executive vice president of products and markets of Centene Corp and former CEO of WellCare Health Plans, Inc from 2015; until Centene bought it in January 2020. propos. Guest Contributions The tables below provide reconciliations of non-GAAP items ($ in millions, except per share data): GAAP net earnings attributable to Centene, Amortization of acquired intangible assets, Acquisition and divestiture related expenses. During the first quarter of 2023, the Company repurchased 4.9million shares for $377 million. The income tax effects of adjustments are based on the effective income tax rates applicable to each adjustment. Terms & Conditions, Temporary Assistance for Needy Families (TANF), Childrens Health Insurance Program (CHIP), Intellectually/Developmentally Disabled (IDD), Federal contracts with the Department of Defense (DoD), Managed Behavioral Healthcare Organization, Credentials Verification Organization (CVO) Certification, Best Place to Work for LGBTQ Equality by the Human Rights Campaign Foundation (2022), Top 50 Company for Diversity by DiversityInc (2022), Top Companies for Black Executives by DiversityInc (2022), Top Companies for Latino Executives by DiversityInc (2022), Leading Disability Employer by the National Organization on Disability (2022), Best Place to Work for Disability Inclusion by the DEI (2022). Centenes healthcare program mainly focuses on government healthcare programs for underinsured and uninsured individuals with a mission to make healthcare accessible to everyone. Brent Layton managed the implementation and development of the latest health plans and global operations. Before becoming a chief operating officer, he used to be responsible for creating new health plans for their clients worldwide. Centene Corporation Executive Team Sarah M. London, Chief Executive Officer Brent Layton, President, and Chief Operating Officer Drew Asher, Chief Financial Officer Shannon Bagley, Executive Vice President, and Chief Administrative Officer Leadership Team Katie Casso, Senior Vice President, Corporate Controller, and Chief Accounting Officer Enter your account data and we will send you a link to reset your password. He joined the company in 2003 as the director of Compensation and Benefits before getting promoted to vice president of Compensation and Benefits and senior vice president of Centenes Human Resources. Four executive leadership appointments were made in March 2021, including Brent Layton, Sarah London, Shannon Bagley, and Robert Sanders. In addition, a digital audio playback will be available until 9:00 AM (Eastern Time) on Tuesday, May 2, 2023, by dialing 1-877-344-7529 in the U.S., 1-855-669-9658 in Canada, or +1-412-317-0088 from abroad, and entering access code 7234123. From this baseline, we remain confident in our ability to deliver 12-15% long-term adjusted earnings compound annual growth in the back half of the decade.". Net earnings per common share attributable to Centene Corporation: Weighted average number of common shares outstanding: Adjustments to reconcile net earnings to net cash provided by operating activities, Net cash provided by operating activities, Divestiture proceeds, net of divested cash, Payments and repurchases of long-term debt, Effect of exchange rate changes on cash, cash equivalents, and restricted cash, Net increase (decrease) in cash, cash equivalents, and restricted cash and cash equivalents, Cash, cash equivalents, and restricted cash and cash equivalents, beginning of period, Cash, cash equivalents, and restricted cash and cash equivalents, end of period. You should not place undue reliance on any forward-looking statements, as actual results may differ materially from projections, estimates, or other forward-looking statements due to a variety of important factors, variables and events including, but not limited to: the impact of COVID-19 on global markets, economic conditions, the healthcare industry and our results of operations and the response by governments and other third parties; the risk that regulatory or other approvals required for the Magellan Acquisition may be delayed or not obtained or are obtained subject to conditions that are not anticipated that could require the exertion of management's time and our resources or otherwise have an adverse effect on us; the risk that Magellan Health's stockholders do not approve the definitive merger agreement; the possibility that certain conditions to the consummation of the Magellan Acquisition will not be satisfied or completed on a timely basis and accordingly the Magellan Acquisition may not be consummated on a timely basis or at all; uncertainty as to the expected financial performance of the combined company following completion of the Magellan Acquisition; the possibility that the expected synergies and value creation from the Magellan Acquisition or the WellCare Acquisition will not be realized, or will not be realized within the applicable expected time periods; the exertion of management's time and our resources, and other expenses incurred and business changes required, in connection with complying with the undertakings in connection with any regulatory, governmental or third party consents or approvals for the Magellan Acquisition; the risk that unexpected costs will be incurred in connection with the completion and/or integration of the Magellan Acquisition or that the integration of Magellan Health will be more difficult or time consuming than expected; the risk that potential litigation in connection with the Magellan Acquisition may affect the timing or occurrence of the Magellan Acquisition or result in significant costs of defense, indemnification and liability; a downgrade of the credit rating of our indebtedness, which could give rise to an obligation to redeem existing indebtedness; the possibility that competing offers will be made to acquire Magellan Health; the inability to retain key personnel; disruption from the announcement, pendency and/or completion and/or integration of the Magellan Acquisition or the integration of the WellCare Acquisition, or similar risks from other acquisitions we may announce or complete from time to time, including potential adverse reactions or changes to business relationships with customers, employees, suppliers or regulators, making it more difficult to maintain business and operational relationships; our ability to accurately predict and effectively manage health benefits and other operating expenses and reserves, including fluctuations in medical utilization rates due to the impact of COVID-19; competition; membership and revenue declines or unexpected trends; changes in healthcare practices, new technologies, and advances in medicine; increased healthcare costs; changes in economic, political or market conditions; changes in federal or state laws or regulations, including changes with respect to income tax reform or government healthcare programs as well as changes with respect to the Patient Protection and Affordable Care Act (ACA) and the Health Care and Education Affordability Reconciliation Act, collectively referred to as the ACA and any regulations enacted thereunder that may result from changing political conditions, the new administration or judicial actions, including the ultimate outcome in "Texas v. United States of America" regarding the constitutionality of the ACA; rate cuts or other payment reductions or delays by governmental payors and other risks and uncertainties affecting our government businesses; our ability to adequately price products; tax matters; disasters or major epidemics; changes in expected contract start dates; provider, state, federal, foreign and other contract changes and timing of regulatory approval of contracts; the expiration, suspension, or termination of our contracts with federal or state governments (including, but not limited to, Medicaid, Medicare, TRICARE or other customers); the difficulty of predicting the timing or outcome of pending or future legal and regulatory proceedings or government investigations; challenges to our contract awards; cyber-attacks or other privacy or data security incidents; the possibility that the expected synergies and value creation from acquired businesses, including businesses we may acquire in the future, will not be realized, or will not be realized within the expected time period; the exertion of management's time and our resources, and other expenses incurred and business changes required in connection with complying with the undertakings in connection with any regulatory, governmental or third party consents or approvals for acquisitions; disruption caused by significant completed and pending acquisitions making it more difficult to maintain business and operational relationships; the risk that unexpected costs will be incurred in connection with the completion and/or integration of acquisition transactions; changes in expected closing dates, estimated purchase price and accretion for acquisitions; the risk that acquired businesses will not be integrated successfully; restrictions and limitations in connection with our indebtedness; our ability to maintain or achieve improvement in the Centers for Medicare and Medicaid Services (CMS) Star ratings and maintain or achieve improvement in other quality scores in each case that can impact revenue and future growth; availability of debt and equity financing, on terms that are favorable to us; inflation; foreign currency fluctuations; and risks and uncertainties discussed in the reports that Centene has filed with the Securities and Exchange Commission.
Compulsive Cheating And Lying, Articles C